Thursday, March 3, 2022 Daily Archives

Canada approves plant-based COVID-19 vax

by

Health Canada has granted authorization for Covifenz, a plant-based COVID-19 vaccine developed by Medicago and GlaxoSmithKline (GSK). Covifenz is made up of plant-based virus-like particles (VLP) and aims to prevent COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals between the ages of 18 to 64 years old. Medicago uses its Proficia technology to synthesize the virus’ code once a virus has been genetically sequenced. In doing so, the firm claims its genetic instructions can then be…

March 3, 2022

Emergent lowers CDMO guidance as J&J assesses COVID vaccine demand

by

Emergent Biosolutions will bring forward maintenance work at its Bayview plant on the back of customer J&J evaluating its COVID-19 vaccine supply network. J&J’s so-called ‘Janssen’ vaccine became the third to be approved under the FDA’s Emergency Use Authorization (EUA) in February 2021, and while the firm had plans to produce one billion doses, the single-shot jab has played third fiddle in Europe and the US to Pfizer and Moderna’ mRNA vaccines. The firm recently told us it has millions…

March 3, 2022